Dr. Julio A. Gutierrez, MD

Dr. Gutierrez practices at Alfa Surgery Center in Chula Vista, California.

Dr. Gutierrez's NPI, 1801092440, was assigned on June 21, 2007. Dr. Gutierrez graduated from Icahn School of Medicine at Mount Sinai in 2007. Dr. Gutierrez holds California license A107985.

Dr. Gutierrez's primary practice is Alfa Surgery Center, at 400 E St, Chula Vista, CA 91910. The practice phone is (619) 621-2622.

Dr. Gutierrez's primary practice is Alfa Surgery Center in Chula Vista, California. Dr. Gutierrez is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Gutierrez to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gutierrez practices, 5 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Gutierrez's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Gutierrez is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, cirrhosis of the liver, colonoscopy, fatty liver, hemorrhoids, hepatitis c and upper GI endoscopy among the conditions Dr. Gutierrez treats.

CMS data shows 610 Medicare services from Dr. Gutierrez across 11 procedure codes in 2024, for 243 Medicare patients. Medicare paid $73,477 for them.

CMS counts 243 Medicare patients who saw Dr. Gutierrez in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gutierrez's median patient age at 64, with 49% women.

In 2024, Dr. Gutierrez wrote 737 Medicare Part D claims for 129 patients. 76% of them were for generic drugs. CMS names the drug for 558 of them, across 19 drugs with 11 or more claims each, at $262,719 in total drug cost. In 2023, CMS named 492 claims across 18 drugs.

Dr. Gutierrez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gutierrez as offering telehealth. CMS counts 16 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gutierrez, more than 47% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Gutierrez, published from 2009 to 2024. 2015 was the busiest year, with 4. The most frequent topics are Antiviral Agents, Hepatitis C and Genotype. Dr. Gutierrez has published most often in Clin Liver Dis. Dr. Gutierrez's most frequent co-authors are Eric J. Lawitz, MD, Carmen Elena Landaverde, MD and Jennifer T. Wells, MD.

CMS Open Payments shows 1,500 general payments to Dr. Gutierrez from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Abbvie Inc. paid the most, $327,562. It also lists 1 research payment totaling $4,000 in 2020.

Dmand AI lists 4 awards for Dr. Gutierrez, most recently Distinguished Fellow in 2009.

Dr. Gutierrez graduated from Icahn School of Medicine at Mount Sinai in 2007.

Dr. Gutierrez is in network with 8 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.